XML 50 R43.htm IDEA: XBRL DOCUMENT v3.21.4

RESEARCH AND DEVELOPMENT - Disclosure of research and development expense (Details) - CAD ($)	4 Months Ended	12 Months Ended
	Sep. 30, 2019	Sep. 30, 2021	Sep. 30, 2020
Research And Development [Line Items]
Research and development expense	$ 42,009	$ 6,313,988	$ 354,852
Laboratory costs [Member]
Research And Development [Line Items]
Research and development expense	27,164	82,871	25,874
Novel drug development [Member]
Research And Development [Line Items]
Research and development expense	0	3,638,910	110,029
Patents and related payments [Member]
Research And Development [Line Items]
Research and development expense	0	513,302	13,895
Salary and subcontractors [Member]
Research And Development [Line Items]
Research and development expense	14,845	1,369,769	43,754
Share-based compensation [Member]
Research And Development [Line Items]
Research and development expense	$ 0	$ 709,136	$ 161,300

X

- References

No definition available.

+ Details

Name:	drug_ResearchAndDevelopmentLineItems
Namespace Prefix:	drug_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2020-01-01
-Paragraph 126
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2020-en-r&anchor=para_126&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_ResearchAndDevelopmentExpense
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	drug_CategoriesOfResearchAndDevelopmentExpensesAxis=drug_LaboratoryCostsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	drug_CategoriesOfResearchAndDevelopmentExpensesAxis=drug_NovelDrugDevelopmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	drug_CategoriesOfResearchAndDevelopmentExpensesAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	drug_CategoriesOfResearchAndDevelopmentExpensesAxis=drug_SalaryAndSubcontractorsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	drug_CategoriesOfResearchAndDevelopmentExpensesAxis=drug_ShareBasedCompensationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: